Page last updated: 2024-08-21

malondialdehyde and Infant, Premature, Diseases

malondialdehyde has been researched along with Infant, Premature, Diseases in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19902 (18.18)18.7374
1990's2 (18.18)18.2507
2000's6 (54.55)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, CC; Keir, AK; Stark, MJ1
Collard, KJ; Godeck, S; Holley, JE; Quinn, MW1
Collard, KJ; Godeck, S; Holley, JE1
Heijnen, CJ; Kavelaars, A; Krediet, TG; van Bel, F; Vreman, HJ1
Bervoets, K; Böhles, H; Schlenzig, JS; von Loewenich, V1
Baines, M; Cooke, RW; Drury, JA; Nycyk, JA1
Hayde, M; Hayn, M; Herkner, K; Lombard, KA; Lubec, G; Pollak, A; Weninger, M; Widness, JA1
Horwitz, AE; Neuhaus, T; Schrod, L; Speer, CP1
Drury, J; Garr, R; Wardle, SP; Weindling, AM1
Aritake, T; Oida, M1
Bankova, VV; Iurkov, IuA; Prishchepova, NF1

Trials

1 trial(s) available for malondialdehyde and Infant, Premature, Diseases

ArticleYear
Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
    Pediatrics, 2001, Volume: 107, Issue:1

    Topics: Administration, Oral; Ascorbic Acid; Blood Cell Count; Drug Therapy, Combination; Erythrocyte Indices; Erythrocyte Transfusion; Erythropoiesis; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Injections, Intravenous; Iron; Malondialdehyde; Prospective Studies; Tyrosine

2001

Other Studies

10 other study(ies) available for malondialdehyde and Infant, Premature, Diseases

ArticleYear
Does non-transferrin bound iron contribute to transfusion related immune-modulation in preterms?
    Archives of disease in childhood. Fetal and neonatal edition, 2013, Volume: 98, Issue:5

    Topics: Enzyme-Linked Immunosorbent Assay; Erythrocyte Transfusion; Female; Humans; Immunomodulation; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Interleukins; Iron; Male; Malondialdehyde; Oxidative Stress; Prospective Studies; Reactive Oxygen Species; Transferrin

2013
Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies.
    Archives of disease in childhood. Fetal and neonatal edition, 2004, Volume: 89, Issue:5

    Topics: Aging; Antioxidants; Ascorbic Acid; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Cohort Studies; Glutathione; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infections; Lipid Peroxidation; Logistic Models; Lung; Malondialdehyde; Oxidative Stress; Oxygen; Prognosis; Respiration, Artificial; Uric Acid

2004
Blood transfusion and pulmonary lipid peroxidation in ventilated premature babies.
    Pediatric pulmonology, 2005, Volume: 39, Issue:3

    Topics: Biomarkers; Blood Transfusion; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipid Peroxidation; Lung; Malondialdehyde; Outcome and Process Assessment, Health Care; Respiration, Artificial; Retrospective Studies

2005
Respiratory distress syndrome-associated inflammation is related to early but not late peri/intraventricular hemorrhage in preterm infants.
    The Journal of pediatrics, 2006, Volume: 148, Issue:6

    Topics: Age Factors; Cerebral Hemorrhage; Cytokines; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Inflammation; Interleukin-6; Interleukin-8; Linear Models; Lipid Peroxidation; Malondialdehyde; Oxidative Stress; Respiratory Distress Syndrome, Newborn; Tumor Necrosis Factor-alpha; Ultrasonography

2006
Urinary malondialdehyde concentration in preterm neonates: is there a relationship to disease entities of neonatal intensive care?
    Acta paediatrica (Oslo, Norway : 1992), 1993, Volume: 82, Issue:2

    Topics: Birth Weight; Bronchopulmonary Dysplasia; Free Radicals; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care, Neonatal; Malondialdehyde; Oxygen; Respiration, Artificial; Retrospective Studies

1993
Does total antioxidant status relate to outcome in very preterm infants?
    Clinical science (London, England : 1979), 1998, Volume: 94, Issue:2

    Topics: Antioxidants; Bilirubin; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipid Peroxidation; Malondialdehyde; Nutritional Status; Respiration, Artificial; Statistics, Nonparametric; Uric Acid

1998
The effect of dexamethasone on respirator-dependent very-low-birth-weight infants is best predicted by chest X-ray.
    Pediatric radiology, 2001, Volume: 31, Issue:5

    Topics: Albumins; Anti-Inflammatory Agents; Chronic Disease; Dexamethasone; Drug Administration Schedule; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Lung; Lung Diseases; Malondialdehyde; Prospective Studies; Radiography; Respiration, Artificial; Secretory Component; Statistics as Topic

2001
Effect of blood transfusion on lipid peroxidation in preterm infants.
    Archives of disease in childhood. Fetal and neonatal edition, 2002, Volume: 86, Issue:1

    Topics: Biomarkers; Blood Transfusion; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Lipid Peroxidation; Malondialdehyde

2002
[Experimental and clinical studies of prematurity and effects of oxygen administration on lipid peroxide in blood (author's transl)].
    Nippon Ganka Gakkai zasshi, 1976, Volume: 80, Issue:10

    Topics: Animals; Chick Embryo; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Malonates; Malondialdehyde; Mice; Oxygen; Retinal Diseases; Vitamin E

1976
[Value of the rate of malondialdehyde accumulation in erythrocytes in the diagnosis of membrane disorders in the premature infant].
    Pediatriia, 1986, Issue:12

    Topics: Cell Membrane; Erythrocytes; Humans; Infant, Newborn; Infant, Premature, Diseases; Malonates; Malondialdehyde; Metabolic Diseases

1986